TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Rowshan Medical AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
15
|
36 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
14
|
35 | |
| EBITDA |
14
|
35 | |
| Total assets |
34
|
64 | |
| Current assets |
34
|
64 | |
| Current liabilities |
19
|
31 | |
| Equity capital |
16
|
33 | |
| - share capital |
5
|
4 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.1%
|
51.6% | |
| Turnover per employee |
15
|
36 | |
| Profit as a percentage of turnover |
93.3%
|
97.2% | |
| Return on assets (ROA) |
41.2%
|
54.7% | |
| Current ratio |
178.9%
|
206.5% | |
| Return on equity (ROE) |
87.5%
|
106.1% | |
| Change turnover |
-21
|
-14 | |
| Change turnover % |
18%
|
-58%
|
-28% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.